Hair Loss in Women and Treatment Options
Hair Loss in Women and Treatment Options
Hair loss has been an issue for men, but in recent years there has been an increase in women experiencing hair loss problems. In men, the most likely cause of hair loss is Androgenetic Alopecia, also known as genetic male pattern hair loss. Although Androgenetic alopecia is frequent cause of hair loss in women, there are many other causes that can contribute to female hair loss. In general, some researchers believe that although male and female pattern hair loss both may have genetic causes, different genes may be involved and therefore female hair loss does not follow the patterns characteristic of genetic hair loss in men.
Hair loss patterns in women are typically different from those in men. hair loss in women tends to be more diffuse than hair loss in men. The more characteristic female pattern is diffuse thinning over a considerable area of the scalp, or diffuse thinning in a Christmas tree pattern over the central scalp.
An advanced form of diffuse thinning is called diffuse unpatterned alopecia. In diffuse female pattern hair loss, some women can benefit from hair transplantation. The procedure has a high success rate in women and the great majority of clients are very happy with the results. However, not all women are candidates for hair transplantation and other options should be discussed and considered.
Women who are not good candidates for hair transplantation may consider a series of oral and topical medications. These medications may include Minoxidil, Spironolactone, Cyproterone Acetate, Cimetidine, Retinoic Acid, and Flutamide. In recent years PRP and ACell injections in the areas of thinning have become very popular and in some cases very helpful. Once the cause of hair loss in women is established, the proper medical treatment should be discussed.
In order to make an accurate assessment of the causes of hair loss in women, extensive lab work should be done and completed. These tests are ordered by Dr. Meshkin before committing to any treatment plan. Female patients should be evaluated and satisfied that all the relevant questions have been addressed regarding any procedures, likely outcomes and the cost for each treatment. Both patient and Dr. Meshkin should be confident that all other causes of hair loss is ruled out before committing to a hair transplantation. A comprehensive treatment option is usually considered when treating female pattern hair loss.
During the initial consultation with the specialist, Dr. Meshkin spends a considerable amount of time to educate the patient utilizing computer hair analysis to evaluate the extent of hair loss, hair loss progression, hair characteristics, and the donor availability. If hair transplant is an option, he will provide an estimate of the number of grafts needed, recommend and explain the best technique of harvesting the grafts that best fits the patient's concerns and goals and the method used for the recipient area. Dr. Meshkin will provide all the information necessary for the patient to make an educated decision for the any surgical or medical hair treatment options available.
Dr. Meshkin is honored to be recognized as a designated long standing member of ISHRS by his peers and also be certified diplomat by ABHRS for his knowledge and skill as a specialized hair restoration surgeon. He has been chosen as Top influencer in REALSELF100 2015 and 2016 for sharing his knowledge and experience in the field of hair restoration. If you are suffering from hair loss, visit one of Dr. Meshkin's hair transplant and hair restoration clinics in Los Angeles or in Irvine locations. Dr. Meshkin will use the latest techniques and gives the best hair restoration recommendations customized to your needs and concerns.
If you have questions about beard transplant, feel free to contact our friendly Meshkin Medical staff. For appointments please call 800-246-8424 or 949-219-0027. We have offices in Beverly Hills, Encino, Orange County, and Glendale. Click here to view our Office Contact information.